印尼与中国合作, 在本地生产负担得起的HPV疫苗. Indonesia partners with China to produce affordable HPV vaccine locally.

印度尼西亚正与中国生物技术公司合作, 以扩大HPV疫苗的获取范围, Indonesia is collaborating with Chinese biotech firms to expand access to the HPV vaccine, aiming to lower costs and improve availability across its vast archipelago. 通过利用技术转让和本地制造,该伙伴关系有助于国家跳过早期开发阶段并增加国内生产的疫苗, 这种疫苗在预防宫癌方面有效率超过90%. By leveraging technology transfer and local manufacturing, the partnership helps the country skip early development phases and increase domestic production of the vaccine, which is over 90% effective in preventing cervical cancer. 官员和家长们欢迎这一进展,认为当地生产的疫苗是让救命免疫更便宜且易于获得的一种方式. Officials and parents welcome the progress, seeing locally produced shots as a way to make life-saving immunizations more affordable and accessible.